ArticleImmunologic research2022

Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels.

Anthony Dobi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.